Literature DB >> 1500207

A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.

T A Mietzner1, J F Kokai-Kun, P C Hanna, B A McClane.   

Abstract

A synthetic peptide homolog corresponding to the C-terminal 30 amino acids of Clostridium perfringens type A enterotoxin (CPE) was conjugated to a thyroglobulin carrier and used to immunize mice. Conjugate-immunized mice produced antibodies which neutralized native CPE cytotoxicity, at least in part, by blocking enterotoxin binding. This peptide may be useful for the development of a vaccine to protect against CPE-mediated disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500207      PMCID: PMC257418          DOI: 10.1128/iai.60.9.3947-3951.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.

Authors:  P C Hanna; T A Mietzner; G K Schoolnik; B A McClane
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Peptide antisera as sequence-specific probes of protein conformational transitions: calmodulin exhibits calcium-dependent changes in antigenicity.

Authors:  J Gariépy; T A Mietzner; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity.

Authors:  B A McClane; A P Wnek
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 5.  Antibodies of predetermined specificity in biology and medicine.

Authors:  R A Lerner
Journal:  Adv Immunol       Date:  1984       Impact factor: 3.543

6.  A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.

Authors:  P C Hanna; B A McClane
Journal:  Mol Microbiol       Date:  1991-01       Impact factor: 3.501

7.  Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

Authors:  A P Wnek; B A McClane
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Evidence that alterations in small molecule permeability are involved in the Clostridium perfringens type A enterotoxin-induced inhibition of macromolecular synthesis in Vero cells.

Authors:  K I Hulkower; A P Wnek; B A McClane
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

9.  Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.

Authors:  P C Hanna; A P Wnek; B A McClane
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

10.  Binding of Clostridium perfringens [125I]enterotoxin to rabbit intestinal cells.

Authors:  J L McDonel
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

View more
  6 in total

Review 1.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.

Authors:  James G Smedley; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

3.  Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis.

Authors:  James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli.

Authors:  J R Czeczulin; P C Hanna; B A McClane
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 5.  Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications.

Authors:  John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Toxins (Basel)       Date:  2016-03-16       Impact factor: 4.546

6.  Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin.

Authors:  Hidehiko Suzuki; Koji Hosomi; Ayaka Nasu; Masuo Kondoh; Jun Kunisawa
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.